149 related articles for article (PubMed ID: 33124483)
1. Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549.
Solanki N; Mehta M; Chellappan DK; Gupta G; Hansbro NG; Tambuwala MM; Aa Aljabali A; Paudel KR; Liu G; Satija S; Hansbro PM; Dua K; Dureja H
Future Med Chem; 2020 Nov; 12(22):2019-2034. PubMed ID: 33124483
[No Abstract] [Full Text] [Related]
2. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
[TBL] [Abstract][Full Text] [Related]
3. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H
Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
5. Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential.
Pandey P; Dua K; Dureja H
Int J Biol Macromol; 2019 Oct; 139():1304-1316. PubMed ID: 31404602
[TBL] [Abstract][Full Text] [Related]
6. Design Graph Theoretical Analysis and
Kunjiappan S; Panneerselvam T; Somasundaram B; Sankaranarayanan M; Parasuraman P; Joshi SD; Arunachalam S; Murugan I
Anticancer Agents Med Chem; 2018; 18(13):1900-1918. PubMed ID: 29956638
[TBL] [Abstract][Full Text] [Related]
7. Anticancer efficacy of 6-thioguanine loaded chitosan nanoparticles with or without curcumin.
Rajashekaraiah R; Kumar PR; Prakash N; Rao GS; Devi VR; Metta M; Narayanaswamy HD; Swamy MN; Satyanarayan K; Rao S; Rathnamma D; Sahadev A; Sunilchandra U; Santhosh CR; Dhanalakshmi H; Kumar SN; Ruban SW; Kalmath GP; Gomes AR; Kumar KRA; Govindappa PK
Int J Biol Macromol; 2020 Apr; 148():704-714. PubMed ID: 31954127
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
9. Trigonelline-loaded chitosan nanoparticles prompted antitumor activity on glioma cells and biocompatibility with pheochromocytoma cells.
Sathiyaseelan A; Saravanakumar K; Jayalakshmi J; Gopi M; Shajahan A; Barathikannan K; Kalaichelvan PT; Wang MH
Int J Biol Macromol; 2020 Nov; 163():36-43. PubMed ID: 32585274
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells.
Teong B; Lin CY; Chang SJ; Niu GC; Yao CH; Chen IF; Kuo SM
J Mater Sci Mater Med; 2015 Jan; 26(1):5357. PubMed ID: 25595721
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery.
Rejinold NS; Muthunarayanan M; Divyarani VV; Sreerekha PR; Chennazhi KP; Nair SV; Tamura H; Jayakumar R
J Colloid Interface Sci; 2011 Aug; 360(1):39-51. PubMed ID: 21549390
[TBL] [Abstract][Full Text] [Related]
13. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of β-boswellic acid derivatives as cytotoxic and apoptotic agents.
Kumar A; Qayum A; Sharma PR; Singh SK; Shah BA
Bioorg Med Chem Lett; 2016 Jan; 26(1):76-81. PubMed ID: 26608550
[TBL] [Abstract][Full Text] [Related]
15. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of ring A modified 11-keto-β-boswellic acid derivatives.
Csuk R; Niesen-Barthel A; Schäfer R; Barthel A; Al-Harrasi A
Eur J Med Chem; 2015 Mar; 92():700-11. PubMed ID: 25618017
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.
Yu X; Hou J; Shi Y; Su C; Zhao L
Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917
[TBL] [Abstract][Full Text] [Related]
18. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
19. Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models.
Abu-Zaied MA; Loutfy SA; Hassan AE; Elgemeie GH
Drug Des Devel Ther; 2019; 13():2437-2457. PubMed ID: 31440030
[No Abstract] [Full Text] [Related]
20. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
